Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Inclusion Criteria:

- Patients, ages 18 years or older who have signed the informed consent

- Has a qualifying skin and skin structure infection

- Female patients must not be pregnant at the time of enrollment

- Must agree to a reliable method of birth control during the study and for 30 days
following the last dose of study drug

Exclusion Criteria:

- Infections where the outcome is strongly influenced by factors other than
protocol-defined treatments and procedures, or that require antibacterial treatment
for greater than 14 days

- Evidence of significant immunological disease

- Severe renal disease or requirement for dialysis

- Evidence of septic shock

- Has a history of hypersensitivity or allergic reaction to any tetracycline or to
linezolid

- Has received an investigational drug within the past 30 days

- Women who are pregnant or nursing